Skip to main content
Erschienen in: Breast Cancer Research and Treatment 3/2020

26.11.2019 | Epidemiology

Pre- and post-diagnostic intake of whole grain and dairy products and breast cancer prognosis: the Danish Diet, Cancer and Health cohort

verfasst von: Julie Louise Munk Andersen, Louise Hansen, Birthe Lykke Riegels Thomsen, Lisa Rudolph Christiansen, Lars Ove Dragsted, Anja Olsen

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Fiber rich foods and dairy products have been suggested to be associated with breast cancer prognosis, though existing research is limited and either report on pre- or post-diagnostic dietary intake in relation to breast cancer prognosis. We investigated the associations between intake of whole grain (WG) and dairy products assessed both pre- and post-diagnostically in relation to breast cancer prognosis.

Methods

A total of 1965 women from the Diet, Cancer and Health cohort who were diagnosed with breast cancer between baseline (1993–1997) and December 2013 were included and followed for a median of 7 years after diagnosis. During follow-up, 309 women experienced breast cancer recurrence and 460 women died, of whom 301 died from breast cancer. Dietary assessment by food frequency questionnaires was obtained up to three times, pre- and post-diagnostic, over a period of 18 years. Cox proportional hazard models were used to estimate hazard ratios.

Results

No associations were observed between pre- or post-diagnostic intake of total WG or total dairy products and breast cancer prognosis. A high pre-diagnostic intake of oatmeal/muesli was associated with lower all-cause mortality (HR 0.76, 95% CI 0.59–0.99), whereas high post-diagnostic intake of rye bread was associated with higher breast cancer-specific mortality (HR 1.29, 95% CI 1.02–1.63). A generally high intake of cheese was associated with a higher recurrence rate.

Conclusion

Pre-diagnostic intake of oatmeal/muesli was associated with lower all-cause mortality, and post-diagnostic intake of rye bread was associated with higher breast cancer specific mortality.
Literatur
3.
Zurück zum Zitat Flachs EM, Eriksen L, Koch MB, Ryd JT, Dibba E, Skov-Ettrup L, Juel K. Statens Institut for Folkesundhed,Syddansk Universitet (2015) Sygdomsbyrden i Danmark – sygdomme. Sundhedsstyrelsen, København Flachs EM, Eriksen L, Koch MB, Ryd JT, Dibba E, Skov-Ettrup L, Juel K. Statens Institut for Folkesundhed,Syddansk Universitet (2015) Sygdomsbyrden i Danmark – sygdomme. Sundhedsstyrelsen, København
8.
Zurück zum Zitat World Cancer Research Fund/American Institute for Cancer Research (2018) Diet, nutrition, physical activity and cancer: a global perspective. Continous Update Project Expert Report 2018. Available at https://dietandcancerreport.org World Cancer Research Fund/American Institute for Cancer Research (2018) Diet, nutrition, physical activity and cancer: a global perspective. Continous Update Project Expert Report 2018. Available at https://​dietandcancerrep​ort.​org
9.
Zurück zum Zitat Slavin JL (2000) Mechanisms for the impact of whole grain foods on cancer risk. J Am Coll Nutr 19(3 Suppl):300S–307SCrossRef Slavin JL (2000) Mechanisms for the impact of whole grain foods on cancer risk. J Am Coll Nutr 19(3 Suppl):300S–307SCrossRef
10.
Zurück zum Zitat Arts CJ, Govers CA, van den Berg H, Wolters MG, van Leeuwen P, Thijssen JH (1991) In vitro binding of estrogens by dietary fiber and the in vivo apparent digestibility tested in pigs. J Steroid Biochem Mol Biol 38(5):621–628CrossRef Arts CJ, Govers CA, van den Berg H, Wolters MG, van Leeuwen P, Thijssen JH (1991) In vitro binding of estrogens by dietary fiber and the in vivo apparent digestibility tested in pigs. J Steroid Biochem Mol Biol 38(5):621–628CrossRef
14.
Zurück zum Zitat Holmes MD, Pollak MN, Willett WC, Hankinson SE (2002) Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomark Prev 11(9):852–861 Holmes MD, Pollak MN, Willett WC, Hankinson SE (2002) Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomark Prev 11(9):852–861
16.
Zurück zum Zitat Xie SP, James SY, Colston KW (1997) Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells. J Endocrinol 154(3):495–504CrossRef Xie SP, James SY, Colston KW (1997) Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells. J Endocrinol 154(3):495–504CrossRef
18.
Zurück zum Zitat Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC (2002) Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst 94(17):1301–1311CrossRef Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC (2002) Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst 94(17):1301–1311CrossRef
19.
Zurück zum Zitat Grimberg A (2003) Mechanisms by which IGF-I may promote cancer. Cancer Biol Ther 2(6):630–635CrossRef Grimberg A (2003) Mechanisms by which IGF-I may promote cancer. Cancer Biol Ther 2(6):630–635CrossRef
21.
Zurück zum Zitat Holmes MD, Stampfer MJ, Colditz GA, Rosner B, Hunter DJ, Willett WC (1999) Dietary factors and the survival of women with breast carcinoma. Cancer 86(5):826–835CrossRef Holmes MD, Stampfer MJ, Colditz GA, Rosner B, Hunter DJ, Willett WC (1999) Dietary factors and the survival of women with breast carcinoma. Cancer 86(5):826–835CrossRef
22.
Zurück zum Zitat World Cancer Research Fund/American Institute for Cancer Research (2018) Continous update project report: diet, nutrition, physical activity and breast cancer 2018. Available at www.dietandcancerreport.org World Cancer Research Fund/American Institute for Cancer Research (2018) Continous update project report: diet, nutrition, physical activity and breast cancer 2018. ​Available at www.​dietandcancerrep​ort.​org
23.
Zurück zum Zitat Pedersen AN, Christensen T, Matthiessen J, Knudsen VK, Rosenlund-Sørensen M, Biltoft-Jensen A, Hinsch HJ, Ygil KH, Kørup K, Saxholt E, Trolle E, Sødergaard AB, Fagt S (2015) Danskernes Kostvaner 2011–2013. 1. Udgave edn. DTU Fødevareinstituttet, Copenhagen Pedersen AN, Christensen T, Matthiessen J, Knudsen VK, Rosenlund-Sørensen M, Biltoft-Jensen A, Hinsch HJ, Ygil KH, Kørup K, Saxholt E, Trolle E, Sødergaard AB, Fagt S (2015) Danskernes Kostvaner 2011–2013. 1. Udgave edn. DTU Fødevareinstituttet, Copenhagen
24.
Zurück zum Zitat Saxe GA, Rock CL, Wicha MS, Schottenfeld D (1999) Diet and risk for breast cancer recurrence and survival. Breast Cancer Res Treat 53(3):241–253CrossRef Saxe GA, Rock CL, Wicha MS, Schottenfeld D (1999) Diet and risk for breast cancer recurrence and survival. Breast Cancer Res Treat 53(3):241–253CrossRef
28.
Zurück zum Zitat Belle FN, Kampman E, McTiernan A, Bernstein L, Baumgartner K, Baumgartner R, Ambs A, Ballard-Barbash R, Neuhouser ML (2011) Dietary fiber, carbohydrates, glycemic index, and glycemic load in relation to breast cancer prognosis in the HEAL cohort. Cancer Epidemiol Biomark Prev 20(5):890–899. https://doi.org/10.1158/1055-9965.EPI-10-1278 CrossRef Belle FN, Kampman E, McTiernan A, Bernstein L, Baumgartner K, Baumgartner R, Ambs A, Ballard-Barbash R, Neuhouser ML (2011) Dietary fiber, carbohydrates, glycemic index, and glycemic load in relation to breast cancer prognosis in the HEAL cohort. Cancer Epidemiol Biomark Prev 20(5):890–899. https://​doi.​org/​10.​1158/​1055-9965.​EPI-10-1278 CrossRef
30.
Zurück zum Zitat Gjertstorff M (2011) The Danish cancer registry. Scand J Public Health 39:42–45CrossRef Gjertstorff M (2011) The Danish cancer registry. Scand J Public Health 39:42–45CrossRef
32.
Zurück zum Zitat Helweg-Larsen K (2011) The Danish register of causes of death. Scand J Public Health 39(7_Suppl):26–29CrossRef Helweg-Larsen K (2011) The Danish register of causes of death. Scand J Public Health 39(7_Suppl):26–29CrossRef
33.
Zurück zum Zitat Mejborn H, Ygil KH, Fagt S, Trolle E, Kørup K, Christiensen T (2014) Wholegrain intake of Danes 2011-2012 Mejborn H, Ygil KH, Fagt S, Trolle E, Kørup K, Christiensen T (2014) Wholegrain intake of Danes 2011-2012
34.
Zurück zum Zitat Tjonneland A, Olsen A, Boll K, Stripp C, Christensen J, Engholm G, Overvad K (2007) Study design, exposure variables, and socioeconomic determinants of participation in diet, cancer and health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35(4):432–441. https://doi.org/10.1080/14034940601047986 CrossRefPubMed Tjonneland A, Olsen A, Boll K, Stripp C, Christensen J, Engholm G, Overvad K (2007) Study design, exposure variables, and socioeconomic determinants of participation in diet, cancer and health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35(4):432–441. https://​doi.​org/​10.​1080/​1403494060104798​6 CrossRefPubMed
Metadaten
Titel
Pre- and post-diagnostic intake of whole grain and dairy products and breast cancer prognosis: the Danish Diet, Cancer and Health cohort
verfasst von
Julie Louise Munk Andersen
Louise Hansen
Birthe Lykke Riegels Thomsen
Lisa Rudolph Christiansen
Lars Ove Dragsted
Anja Olsen
Publikationsdatum
26.11.2019
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 3/2020
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-019-05497-1

Weitere Artikel der Ausgabe 3/2020

Breast Cancer Research and Treatment 3/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.